Cat Allergy in Humans Market - Rising Incidence of Cat Allergy Instances is Expected to Lead the Market Growth – Growing at a Compound Annual Growth Rate (CAGR) 5.8% from 2022 to 2028

As stated in our extensive report, the Global Cat Allergy in Humans Market accounted for USD 3.9 Billion in the year 2021.

Cats are becoming more popular as pets, causing allergic reactions in their 10;Cat allergy, for example, is widespread in the United States and Europe; skin prick tests suggest that 17% of the U.S. population and 8% of the EU population are allergic to cats. In addition, certain families appear to be more prone to allergic reactions than others. As a result, children born into these households are more prone to suffer from allergies. This inherited susceptibility to acquiring such disorders is linked to atopic dermatitis. The identification and treatment of allergy sufferers are difficult. However, continuous exposure to cat allergens is thought to cause allergic sensitization and the development of clinically significant allergy 160;

People with chronic respiratory problems, as previously stated, are at a higher risk of acquiring a cat allergy. As a result of the rise in chronic respiratory illness patients, the global market for cat allergy treatment is expanding rapidly. Emphysema (COPD) and asthma, for example, are considered essential factors that can cause cat allergy in a considerable percentage of the global population. The market is likely to rise as people become more aware of the symptoms of allergic reactions to cats. The rising incidence of cat allergy instances is pushing people worldwide to utilize allergy medication to avoid allergic reactions. As a result, human-cat allergy is increasing at an alarming 10;Growing awareness of allergies, the rising prevalence of cat allergies, and other factors contribute to the Cat Allergy in Humans Market's expansion. Increased desire for natural products is one factor that is likely to have a significant impact on global cat allergy in humans in the future.

North America has led the growth of the Global Cat Allergy in Humans Market in 2021. The expansion of the market in North America is attributable to an increase in the number of pet cats and a high prevalence of cat allergies among individuals.

The well-known players of the Global Cat Allergy in Humans Market include Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma), Cipla Limited, GlaxoSmithKline plc, Merck & Co. Inc, Regeneron Pharmaceuticals Inc, Saiba Animal Health AG, Sanofi, Stallergenes Greer., Other prominent players and others.